The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal challenge in the high court in London, a UK media report said on......
But no extra risk after second dose, shows study led and funded by drug maker, reports Sohini Das. IMAGE: Syringes containing the AstraZeneca coronavirus vaccine sit on a metal tray before being......
The Centre on Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks following a recommendation from a government panel, and said it is a 'science-based......
The United Kingdom’s medicines regulator has confirmed seven cases of blood clot-related deaths in people who received the Oxford/AstraZeneca vaccine against COVID-19, but stressed on the......
The vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe and there is no evidence to suggest that the jabs are the cause behind blood clots......
Not satisfied with the report submitted before it on health condition of former chairman of Satyam Computer Services B Ramalinga Raju, a local court on Friday asked a city hospital to file a fresh......